Maraganore John

Maraganore John is listed in filings as Director at Rapport Therapeutics, Inc. Common Stock. This profile follows SEC Form 4 activity through Jun 5, 2026, including 4 public disclosures. Recent filings connect the profile to Rapport Therapeutics, Inc. Common Stock (RAPP), Kymera Therapeutics, Inc. (KYMR), and Beam Therapeutics Inc. (BEAM). The current snapshot covers public activity from Jun 6, 2025 to Jun 5, 2026. Reported amounts are shown as $239.3K to $577.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.